Semaglutide is a glucagon-like peptide-1 agonist (GLP-1) that is prescribed to treat obesity. It is a once-weekly injection. GLP-1 medications have been found to reduce hunger, increase satiety, and delay gastric emptying so that people feel full longer. GLP-1 medications have been found to be effective for long-term weight loss, making it an ideal treatment for many who struggle with weight. Studies show that people may lose up to 15% of their body weight, especially when combined with diet and exercise. This is a unique compounded Semaglutide (combined with B12) that has the same active weight loss ingredient as the commercial brands Ozempic® and Wegovy® and is available to people who meet the criteria for use.
*Only certain dosages are available in CA
Pharmaceutical products are only available to members of the Lifeforce Membership ($149/month) and are contingent on blood tests results and clinician video consult. To qualify for the program you must reside in an eligible state* and purchase a Lifeforce Diagnostic ($599).
Semaglutide is a glucagon-like peptide-1 agonist (GLP-1) that is prescribed to treat obesity. It is a once-weekly injection. GLP-1 medications have been found to reduce hunger, increase satiety, and delay gastric emptying so that people feel full longer. GLP-1 medications have been found to be effective for long-term weight loss, making it an ideal treatment for many who struggle with weight. Studies show that people may lose up to 15% of their body weight, especially when combined with diet and exercise. This is a unique compounded Semaglutide (combined with B12) that has the same active weight loss ingredient as the commercial brands Ozempic® and Wegovy® and is available to people who meet the criteria for use.
*Only certain dosages are available in CA
Pharmaceutical products are only available to members of the Lifeforce Membership ($149/month) and are contingent on blood tests results and clinician video consult. To qualify for the program you must reside in an eligible state* and purchase a Lifeforce Diagnostic ($599).
Semaglutide works via multiple mechanisms to reduce appetite and promote weight loss of 10-15%
Helps to lower blood sugar after meals by lower glucagon and increasing insulin levels
Studies have shown reduced heart disease risk with semaglutide, regardless of how much weight loss was achieved
Semaglutide is a glucagon-like peptide-1 agonist (GLP-1) that is prescribed to treat obesity. It is a once-weekly injection. GLP-1 medications have been found to reduce hunger, increase satiety, and delay gastric emptying so that people feel full longer. GLP-1 medications have been found to be effective for long-term weight loss, making it an ideal treatment for many who struggle with weight. Studies show that people may lose up to 15% of their body weight, especially when combined with diet and exercise. This is a unique compounded Semaglutide (combined with B12) that has the same active weight loss ingredient as the commercial brands Ozempic® and Wegovy® and is available to people who meet the criteria for use.
*Only certain dosages are available in CA
Pharmaceutical products are only available to members of the Lifeforce Membership ($149/month) and are contingent on blood tests results and clinician video consult. To qualify for the program you must reside in an eligible state* and purchase a Lifeforce Diagnostic ($599).
Stimulate energy and metabolism by replenishing T3 and T4.
Prevent glucose spikes with a tablet that increases insulin sensitivity and disposes of excess glucose in the liver, muscle, fat, and brain.
Fight age-related hormonal decline.
Support long-term weight loss with this FDA-approved injectable.